Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
1.2Registration to an optical surface scan
What ifWhat if the magnetic particle image were aligned to an optical surface scan of the organ?
A rigid cradle carries markers with an optically visible shell and a magnet-responsive core. A structured-light scanner records the organ surface and marker positions, and a rigid coordinate transform aligns the particle distribution with the organ surface.
1.3Slow cooling with glass formation
What ifWhat if the perfused organ were cooled slowly with a cryoprotectant formulation that forms a glass at the selected cooling rate?
Claim language“rapidly cooling the perfused ex vivo organ”
A perfusion pump loads a small organ with a concentrated mixture of permeating cryoprotectants. A programmable chamber ramps the temperature above the loaded tissue's critical cooling rate for vitrification while limiting the temperature difference between the core and surface.
1.4Spectral x-ray particle mapping
What ifWhat if the particle distribution were mapped by spectral X-ray tomography?
Claim language“using magnetic particle imaging”
The magnet-responsive particles carry an X-ray attenuating coating with a fixed ratio of contrast material to magnetic material. A spectral scanner separates the coating signal from tissue attenuation, and calibration samples convert that signal into a particle concentration map.
1.5Temperature control from slice maps
What ifWhat if the registered images were used as individual slice maps for probe placement and temperature control?
Claim language“generating 3D computational models”
An operator marks particle-rich and particle-poor regions on selected registered slices and places fiber-optic temperature probes at the corresponding sites. A controller reduces heating power when the hottest probe reaches its limit and ends the warming cycle when the coldest probe reaches the target temperature.
1.6Rewarming in a circulating bath
What ifWhat if a small, thin organ were rewarmed by heat transfer from a circulating liquid bath?
Claim language“applying an effective alternating magnetic field”
A thin-walled sealed pouch holds the organ in cryoprotectant while a pump circulates temperature-controlled liquid around both faces of the pouch. Heat conducts inward over the short distance to the organ center, and a fiber-optic probe tracks the center temperature through the warming interval.
Section 2 · machine-generated
Variations
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Other field of use
Rewarming fish ovaries for hatcheries
A hatchery preservation station introduces a cryoprotectant containing magnetic particles through the vascular inlet of an excised fish ovary. Magnetic particle images are aligned with computed tomography images of the ovary in its holder to map particle loading across the two lobes. After cryogenic cooling, an external alternating-field coil warms the ovary while fiber-optic probes in both lobes supply temperature readings to the coil controller.
Component substitution
Ultrasound mapping of organ anatomy
A tracked three-dimensional ultrasound probe supplies the anatomical volume in place of magnetic resonance or computed tomography. Before cooling, the probe sweeps the perfused organ in a rigid holder with a coupling bath and fiducials visible in both ultrasound and magnetic particle images. The software aligns the two volumes using the fiducials and overlays the particle map on the ultrasound-derived organ boundary. Fiber-optic temperature probes at positions selected from the overlay feed the external coil controller during warming.
Pulsed heating with fixed coil current
A resonant inverter with burst gating sets heating power in place of continuous coil current adjustment. The inverter drives the external coil at a fixed frequency and peak current during each burst, and the controller changes the fraction of each control interval occupied by bursts. The registered particle map guides probe placement, and measured temperature and heating rate determine the next burst fraction. A separate temperature limit input disables the gate when any probe reaches its configured upper limit.
Parameter or scale variation
Two heating zones for elongated organs
A holder carries an elongated organ in two adjacent solenoid coils with axial centers 60 mm apart and independent current commands. The registered particle map divides the organ into two axial control regions, with two fiber-optic temperature probes in each region. The controller samples the four probes at 10 Hz and updates each coil current command once per second. The colder reading in each region sets the heating demand, and the warmer reading limits the command as the region approaches the terminal temperature.
Combination with existing systems
Rewarming integrated with machine perfusion
A common organ cradle docks in an external rewarming coil and connects to a machine perfusion circuit through nonmetallic inlet and outlet lines. The inlet and outlet remain clamped during magnetic warming, and the circuit primes a separate branch with temperature-conditioned washout fluid. When the temperature probes reach the terminal range, the coil switches off and the circuit pumps washout fluid through the organ to a collection vessel. The circuit then switches to a recirculating oxygenated perfusate and controls flow using inlet pressure measurements.
Automated or data-driven variant
Automatic placement of temperature probes
Software segments the organ boundary and major vessels from the anatomical volume and overlays the registered magnetic particle concentration map. It ranks low-loading interior sites and high-loading peripheral sites, then selects probe paths that stay clear of the segmented vessels. A motorized positioning stage aligns a guide with each selected path and inserts a fiber-optic probe to the computed depth before cooling. The software assigns each probe to a region in the model and routes its readings to the corresponding temperature feedback input during rewarming.
Specific version of a part
Pumped arterial perfusion with particles
A peristaltic pump delivers cryoprotectant through a cannula in the organ's main artery, and a pressure transducer measures pressure at the cannula inlet. The final perfusate contains polymer-coated iron oxide particles dispersed in the cryoprotectant.
Three-dimensional heat transfer mesh
Registered tomographic images provide the organ boundary, and the particle image provides local particle concentration. A tetrahedral finite-element mesh assigns a heat generation rate to each element from the local concentration and models heat conduction through the tissue.
Water-cooled solenoid for inductive heating
A radio-frequency power supply drives a solenoid wound from hollow copper tubing around a nonconductive sample chamber. Coolant flows through the tubing, and the alternating magnetic field heats the particles dispersed in the organ.
Feedback from multiple temperature probes
Fiber-optic probes measure temperatures at the organ center and at several surface sites. A proportional-integral controller adjusts coil power to track a programmed warming ramp and reduces power when any probe reaches its temperature limit.
Section 3 · quoted from USPTO records
Other work
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
1.1perfusing an ex vivo organ with a biological tissue preservation cryoprotectant composition comprising magnet-responsive particles;
In one aspect, the present disclosure relates to methods for preserving a biological tissue sample, the method including: (a) perfusing the biological tissue sample with a sub-normothermic perfusion solution including one or more cryoprotective agents, one or more oxygen carrier agents, one or more growth factors, and one or more vasodilators, at a sub-normothermic temperature;
B · US 2022/0095607 A1 · ¶ 7
1.2scanning the ex vivo organ using magnetic particle imaging co-registered with previously acquired radiological images (MRI, CT); and
1.3rapidly cooling the perfused ex vivo organ to a first temperature without inducing ice crystallization or cracking;
The present disclosure relates to improved supercooling protocols that avert freezing and crystal formation in the cells of tissue samples, e.g., mammalian, e.g., human tissue samples, such as whole organs, e.g., liver, heart, kidney, bone, lung, skin, eye, ovary, pancreas, or any tissues that can be perfused through a vessel such as limbs and other vascular composite allografts.
A · US 2021/0195891 A1 · ¶ 43
(6) Chilling (slowly enough to prevent freezing/formation of ice crystals, e.g., at a rate of about −0.1° C./minute) the biological tissue sample in a subzero non-freezing preservation solution to a subzero temperature (e.g., −2 to −7° C., e.g., −5° C.) without freezing, e.g., by a method wherein the biological tissue sample is placed in a container (e.g., an organ isolation bag), air is removed from the container to reduce liquid-air interfaces (this step results in subzero
B · US 2022/0095607 A1 · ¶ 64
1.4scanning an ex vivo organ using magnetic particle imaging to generate one or more images representing a distribution of magnetic particles within the ex vivo organ;
1.5co-registering the magnetic particle imaging with MRI and/or CT imaging of the biological tissue generating 3D computational models for the biological tissue from co-registered images;
1.6applying an effective alternating magnetic field to the ex vivo organ using a magnetic field coil that is external to the ex vivo organ; and
Improved tissue cryopreservation using inductive heating of magnetic nanoparticles.
A · US 2021/0195891 A1 · ¶
1.7warming the ex vivo organ from a first temperature to a second temperature using automated feedback control.
The liver and perfusate temperature are controlled by a separated warming/cooling circuit. Water or refrigerant is either warmed by a warm water bath (ThermoFisher Scientific, Pittsburgh, Pa., USA) or cooled by a chiller (Optitemp, Traverse City, Mich., USA) respectively, and pumped through the heat exchangers and the jackets of the bubble traps and the organ chamber.
A · US 2021/0195891 A1 · ¶ 143
In some embodiments, the perfusate and/or biological tissue sample temperature can be controlled by a separated warming/cooling circuits. The warming circuit can warmed by a warm water bath, while the cooling circuit can be cooled by a chiller.
B · US 2022/0095607 A1 · ¶ 98
An empty cell means only that no passage was reproduced there.
Statements in these documents
However, scalability of supercooling preservation to human organs is intrinsically limited due to volume dependent stochastic ice formation at these subzero temperatures.
A · US 2021/0195891 A1 · ¶ 5
The present disclosure relates to methods of subzero preservation of biological tissue samples, such as entire organs from mammals, e.g., humans.
A · US 2021/0195891 A1 · ¶ 6
Permanent ischemic injury occurs within 2-4 hours of warm ischemia and 6-8 hours of cold ischemia in skeletal muscle, which is abundant in amputated limbs.
B · US 2022/0095607 A1 · ¶ 4
The methods can include the use of growth factors, oncotic agents and/or a multi-step protocol as described herein to minimize swelling and enhance VCA viability.
B · US 2022/0095607 A1 · ¶ 6
Cite aspatent.fyi, US 2026/0354374 A1, claim 1, first published 2026-11-18T21:55:14-05:00, https://patent.fyi/US20260354374/, SHA-256 aaf0f23663d4b8e4b38326f02da75103179376983702aa1c672710204d921c96